117 related articles for article (PubMed ID: 32968485)
1. Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma.
Muhetaer A; Niyaz M; Ainiwaer J; Liwei Z; Awut E
Mol Clin Oncol; 2020 Nov; 13(5):64. PubMed ID: 32968485
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang.
Zhang L; Wang Y; Bai G; Zhang J; Yang M; Ma X
Tumour Biol; 2015 Dec; 36(12):9277-83. PubMed ID: 26099724
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.
Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM
Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592
[TBL] [Abstract][Full Text] [Related]
4. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
[TBL] [Abstract][Full Text] [Related]
6. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma.
Huang JX; Zhao K; Lin M; Wang Q; Xiao W; Lin MS; Yu H; Chen P; Qian RY
Oncol Lett; 2013 Jul; 6(1):13-18. PubMed ID: 23946770
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
8. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Li J; Xie Y; Wang X; Jiang C; Yuan X; Zhang A; Liu C; Pang L; Li F; Hu J
PeerJ; 2019; 7():e8182. PubMed ID: 31824776
[TBL] [Abstract][Full Text] [Related]
10. Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance.
Niyaz M; Ainiwaer J; Abudureheman A; Zhang L; Sheyhidin I; Turhong A; Cai R; Hou Z; Awut E
Oncol Lett; 2020 Aug; 20(2):1855-1865. PubMed ID: 32724429
[TBL] [Abstract][Full Text] [Related]
11. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
12. The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C, plays an important role in Kazakh ESCC invasion and metastasis.
Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Yang L; Chen YZ; Liu CX; Li SG; Cui XB; Zou H; Pang LJ; Zhao J; Qi Y; Liang WH; Yuan XL; Li F
Exp Mol Pathol; 2017 Feb; 102(1):15-21. PubMed ID: 27939650
[TBL] [Abstract][Full Text] [Related]
13. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
15. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
17. CEP3 and CEP17 DNA probe potential in the genetic diagnosis and prognostic prediction of esophageal squamous cell cancer.
Niyaz M; Abdurahman A; Turghun A; Awut I
Exp Ther Med; 2016 Apr; 11(4):1375-1380. PubMed ID: 27073452
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HLA-G Is positively associated with Kazakh esophageal squamous cell carcinoma in Xinjiang, China.
Hu J; Li L; Liu Y; Chen Y; Liu C; Liang W; Zhao J; Zou H; Cui X; Qi Y; Li L; Feng L
Viral Immunol; 2013 Jun; 26(3):180-4. PubMed ID: 23772974
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]